Securin (hPTTG1) expression is regulated by beta-catenin/TCF in human colorectal carcinoma

Br J Cancer. 2006 Jun 5;94(11):1672-7. doi: 10.1038/sj.bjc.6603155.

Abstract

Overexpression of the transcriptional activator beta-catenin, mostly owing to loss-of-function mutations of the adenomatous polyposis coli (APC) tumour suppressor gene, is crucial for the initiation and progression of human colorectal carcinogenesis. Securin is a regulator of chromosome separation and its overexpression has been shown to be involved in different tumour-promoting processes, like transformation, hyperproliferation and angiogenesis, and correlates with tumour cell invasion. However, the molecular mechanism leading to securin overexpression in human colorectal cancer is unknown. Here we show a correlated high expression of beta-catenin and securin (hPTTG1) in colorectal adenomas and carcinomas and further demonstrate that securin is a target of beta-catenin transcriptional activation. This implies that deregulation of the beta-catenin/T-cell factor-signalling pathway leads to overexpression of securin in human colorectal cancer, which subsequently may contribute to tumour progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / genetics*
  • Adenocarcinoma / surgery
  • Binding Sites
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / surgery
  • DNA Primers
  • Gene Expression Regulation, Neoplastic / physiology*
  • Humans
  • Neoplasm Proteins / blood*
  • Neoplasm Proteins / genetics*
  • Oligonucleotide Array Sequence Analysis
  • Promoter Regions, Genetic
  • RNA Interference
  • Reverse Transcriptase Polymerase Chain Reaction
  • Securin
  • TCF Transcription Factors / metabolism*
  • beta Catenin / metabolism*

Substances

  • DNA Primers
  • Neoplasm Proteins
  • Securin
  • TCF Transcription Factors
  • beta Catenin
  • pituitary tumor-transforming protein 1, human